nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—Labetalol—Salmeterol—asthma	0.242	0.348	CrCrCtD
Lisdexamfetamine—Labetalol—Formoterol—asthma	0.161	0.23	CrCrCtD
Lisdexamfetamine—Labetalol—Arformoterol—asthma	0.161	0.23	CrCrCtD
Lisdexamfetamine—Labetalol—Isoprenaline—asthma	0.134	0.192	CrCrCtD
Lisdexamfetamine—Lisinopril—ACE—asthma	0.00056	0.602	CrCbGaD
Lisdexamfetamine—Labetalol—ADRB2—asthma	0.00037	0.398	CrCbGaD
Lisdexamfetamine—Weight increased—Betamethasone—asthma	0.000153	0.000601	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Budesonide—asthma	0.000153	0.000601	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Montelukast—asthma	0.000153	0.0006	CcSEcCtD
Lisdexamfetamine—Headache—Flunisolide—asthma	0.000152	0.000598	CcSEcCtD
Lisdexamfetamine—Weight decreased—Betamethasone—asthma	0.000152	0.000598	CcSEcCtD
Lisdexamfetamine—Weight decreased—Dexamethasone—asthma	0.000152	0.000598	CcSEcCtD
Lisdexamfetamine—Asthenia—Formoterol—asthma	0.000152	0.000597	CcSEcCtD
Lisdexamfetamine—Asthenia—Arformoterol—asthma	0.000152	0.000597	CcSEcCtD
Lisdexamfetamine—Asthenia—Montelukast—asthma	0.000149	0.000584	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Dexamethasone—asthma	0.000148	0.000581	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Betamethasone—asthma	0.000148	0.000581	CcSEcCtD
Lisdexamfetamine—Hallucination—Methylprednisolone—asthma	0.000147	0.000579	CcSEcCtD
Lisdexamfetamine—Eye disorder—Hydrocortisone—asthma	0.000147	0.000579	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Salbutamol—asthma	0.000147	0.000578	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Dexamethasone—asthma	0.000147	0.000578	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Betamethasone—asthma	0.000147	0.000578	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Formoterol—asthma	0.000145	0.000569	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Arformoterol—asthma	0.000145	0.000569	CcSEcCtD
Lisdexamfetamine—Nausea—Flunisolide—asthma	0.000144	0.000567	CcSEcCtD
Lisdexamfetamine—Asthenia—Salbutamol—asthma	0.000143	0.000563	CcSEcCtD
Lisdexamfetamine—Vomiting—Mometasone—asthma	0.000143	0.000563	CcSEcCtD
Lisdexamfetamine—Visual impairment—Methylprednisolone—asthma	0.000142	0.00056	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Budesonide—asthma	0.000142	0.00056	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Hydrocortisone—asthma	0.000142	0.000559	CcSEcCtD
Lisdexamfetamine—Rash—Mometasone—asthma	0.000142	0.000559	CcSEcCtD
Lisdexamfetamine—Dermatitis—Mometasone—asthma	0.000142	0.000558	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Montelukast—asthma	0.000142	0.000557	CcSEcCtD
Lisdexamfetamine—Headache—Mometasone—asthma	0.000141	0.000555	CcSEcCtD
Lisdexamfetamine—Dizziness—Formoterol—asthma	0.00014	0.00055	CcSEcCtD
Lisdexamfetamine—Dizziness—Arformoterol—asthma	0.00014	0.00055	CcSEcCtD
Lisdexamfetamine—Asthenia—Budesonide—asthma	0.000139	0.000546	CcSEcCtD
Lisdexamfetamine—Eye disorder—Methylprednisolone—asthma	0.000138	0.000544	CcSEcCtD
Lisdexamfetamine—Mental disorder—Hydrocortisone—asthma	0.000138	0.000542	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Methylprednisolone—asthma	0.000137	0.00054	CcSEcCtD
Lisdexamfetamine—Malnutrition—Hydrocortisone—asthma	0.000137	0.000539	CcSEcCtD
Lisdexamfetamine—Dizziness—Montelukast—asthma	0.000137	0.000539	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Salbutamol—asthma	0.000137	0.000537	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Prednisone—asthma	0.000135	0.00053	CcSEcCtD
Lisdexamfetamine—Vomiting—Formoterol—asthma	0.000134	0.000529	CcSEcCtD
Lisdexamfetamine—Vomiting—Arformoterol—asthma	0.000134	0.000529	CcSEcCtD
Lisdexamfetamine—Hallucination—Dexamethasone—asthma	0.000134	0.000526	CcSEcCtD
Lisdexamfetamine—Hallucination—Betamethasone—asthma	0.000134	0.000526	CcSEcCtD
Lisdexamfetamine—Nausea—Mometasone—asthma	0.000134	0.000526	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Methylprednisolone—asthma	0.000134	0.000525	CcSEcCtD
Lisdexamfetamine—Rash—Arformoterol—asthma	0.000133	0.000524	CcSEcCtD
Lisdexamfetamine—Rash—Formoterol—asthma	0.000133	0.000524	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Methylprednisolone—asthma	0.000133	0.000524	CcSEcCtD
Lisdexamfetamine—Dermatitis—Formoterol—asthma	0.000133	0.000524	CcSEcCtD
Lisdexamfetamine—Dermatitis—Arformoterol—asthma	0.000133	0.000524	CcSEcCtD
Lisdexamfetamine—Weight increased—Prednisone—asthma	0.000133	0.000524	CcSEcCtD
Lisdexamfetamine—Headache—Arformoterol—asthma	0.000132	0.000521	CcSEcCtD
Lisdexamfetamine—Headache—Formoterol—asthma	0.000132	0.000521	CcSEcCtD
Lisdexamfetamine—Weight decreased—Prednisone—asthma	0.000132	0.000521	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Budesonide—asthma	0.000132	0.00052	CcSEcCtD
Lisdexamfetamine—Vision blurred—Prednisolone—asthma	0.000132	0.00052	CcSEcCtD
Lisdexamfetamine—Dizziness—Salbutamol—asthma	0.000132	0.000519	CcSEcCtD
Lisdexamfetamine—Vomiting—Montelukast—asthma	0.000132	0.000518	CcSEcCtD
Lisdexamfetamine—Rash—Montelukast—asthma	0.000131	0.000514	CcSEcCtD
Lisdexamfetamine—Dermatitis—Montelukast—asthma	0.00013	0.000513	CcSEcCtD
Lisdexamfetamine—Depression—Prednisone—asthma	0.00013	0.000512	CcSEcCtD
Lisdexamfetamine—Headache—Montelukast—asthma	0.00013	0.00051	CcSEcCtD
Lisdexamfetamine—Visual impairment—Betamethasone—asthma	0.00013	0.00051	CcSEcCtD
Lisdexamfetamine—Visual impairment—Dexamethasone—asthma	0.00013	0.00051	CcSEcCtD
Lisdexamfetamine—Mental disorder—Methylprednisolone—asthma	0.00013	0.00051	CcSEcCtD
Lisdexamfetamine—Malnutrition—Methylprednisolone—asthma	0.000129	0.000506	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Prednisone—asthma	0.000129	0.000506	CcSEcCtD
Lisdexamfetamine—Angioedema—Prednisolone—asthma	0.000128	0.000504	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Prednisone—asthma	0.000128	0.000503	CcSEcCtD
Lisdexamfetamine—Dizziness—Budesonide—asthma	0.000128	0.000503	CcSEcCtD
Lisdexamfetamine—Vomiting—Salbutamol—asthma	0.000127	0.000499	CcSEcCtD
Lisdexamfetamine—Rash—Salbutamol—asthma	0.000126	0.000495	CcSEcCtD
Lisdexamfetamine—Dermatitis—Salbutamol—asthma	0.000126	0.000495	CcSEcCtD
Lisdexamfetamine—Eye disorder—Betamethasone—asthma	0.000126	0.000494	CcSEcCtD
Lisdexamfetamine—Eye disorder—Dexamethasone—asthma	0.000126	0.000494	CcSEcCtD
Lisdexamfetamine—Nausea—Arformoterol—asthma	0.000126	0.000494	CcSEcCtD
Lisdexamfetamine—Nausea—Formoterol—asthma	0.000126	0.000494	CcSEcCtD
Lisdexamfetamine—Angioedema—Hydrocortisone—asthma	0.000125	0.000492	CcSEcCtD
Lisdexamfetamine—Headache—Salbutamol—asthma	0.000125	0.000492	CcSEcCtD
Lisdexamfetamine—Nausea—Montelukast—asthma	0.000123	0.000484	CcSEcCtD
Lisdexamfetamine—Vomiting—Budesonide—asthma	0.000123	0.000484	CcSEcCtD
Lisdexamfetamine—Rash—Budesonide—asthma	0.000122	0.00048	CcSEcCtD
Lisdexamfetamine—Dermatitis—Budesonide—asthma	0.000122	0.000479	CcSEcCtD
Lisdexamfetamine—Convulsion—Prednisolone—asthma	0.000122	0.000478	CcSEcCtD
Lisdexamfetamine—Headache—Budesonide—asthma	0.000121	0.000476	CcSEcCtD
Lisdexamfetamine—Hypertension—Prednisolone—asthma	0.000121	0.000476	CcSEcCtD
Lisdexamfetamine—Convulsion—Hydrocortisone—asthma	0.000119	0.000467	CcSEcCtD
Lisdexamfetamine—Nausea—Salbutamol—asthma	0.000119	0.000466	CcSEcCtD
Lisdexamfetamine—Hypertension—Hydrocortisone—asthma	0.000118	0.000465	CcSEcCtD
Lisdexamfetamine—Angioedema—Triamcinolone—asthma	0.000118	0.000464	CcSEcCtD
Lisdexamfetamine—Angioedema—Methylprednisolone—asthma	0.000118	0.000463	CcSEcCtD
Lisdexamfetamine—Hallucination—Prednisone—asthma	0.000116	0.000458	CcSEcCtD
Lisdexamfetamine—Anxiety—Hydrocortisone—asthma	0.000116	0.000457	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	0.000116	0.000456	CcSEcCtD
Lisdexamfetamine—Nausea—Budesonide—asthma	0.000115	0.000452	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Prednisolone—asthma	0.000114	0.00045	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Hydrocortisone—asthma	0.000112	0.00044	CcSEcCtD
Lisdexamfetamine—Convulsion—Triamcinolone—asthma	0.000112	0.00044	CcSEcCtD
Lisdexamfetamine—Tachycardia—Prednisolone—asthma	0.000112	0.00044	CcSEcCtD
Lisdexamfetamine—Convulsion—Methylprednisolone—asthma	0.000111	0.000439	CcSEcCtD
Lisdexamfetamine—Hypertension—Triamcinolone—asthma	0.000111	0.000438	CcSEcCtD
Lisdexamfetamine—Hypertension—Methylprednisolone—asthma	0.000111	0.000437	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Prednisolone—asthma	0.000111	0.000435	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Hydrocortisone—asthma	0.00011	0.000431	CcSEcCtD
Lisdexamfetamine—Eye disorder—Prednisone—asthma	0.000109	0.00043	CcSEcCtD
Lisdexamfetamine—Anxiety—Methylprednisolone—asthma	0.000109	0.00043	CcSEcCtD
Lisdexamfetamine—Tachycardia—Hydrocortisone—asthma	0.000109	0.000429	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	0.000109	0.000428	CcSEcCtD
Lisdexamfetamine—Skin disorder—Hydrocortisone—asthma	0.000109	0.000427	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Hydrocortisone—asthma	0.000108	0.000425	CcSEcCtD
Lisdexamfetamine—Dry mouth—Triamcinolone—asthma	0.000107	0.000422	CcSEcCtD
Lisdexamfetamine—Angioedema—Betamethasone—asthma	0.000107	0.000421	CcSEcCtD
Lisdexamfetamine—Angioedema—Dexamethasone—asthma	0.000107	0.000421	CcSEcCtD
Lisdexamfetamine—Anorexia—Hydrocortisone—asthma	0.000107	0.000419	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Prednisone—asthma	0.000106	0.000416	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Triamcinolone—asthma	0.000105	0.000414	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Methylprednisolone—asthma	0.000105	0.000413	CcSEcCtD
Lisdexamfetamine—Insomnia—Prednisolone—asthma	0.000104	0.000407	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Methylprednisolone—asthma	0.000103	0.000405	CcSEcCtD
Lisdexamfetamine—Tachycardia—Triamcinolone—asthma	0.000103	0.000404	CcSEcCtD
Lisdexamfetamine—Mental disorder—Prednisone—asthma	0.000103	0.000404	CcSEcCtD
Lisdexamfetamine—Tachycardia—Methylprednisolone—asthma	0.000102	0.000403	CcSEcCtD
Lisdexamfetamine—Skin disorder—Methylprednisolone—asthma	0.000102	0.000401	CcSEcCtD
Lisdexamfetamine—Malnutrition—Prednisone—asthma	0.000102	0.000401	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Triamcinolone—asthma	0.000102	0.0004	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Methylprednisolone—asthma	0.000102	0.000399	CcSEcCtD
Lisdexamfetamine—Convulsion—Dexamethasone—asthma	0.000101	0.000399	CcSEcCtD
Lisdexamfetamine—Convulsion—Betamethasone—asthma	0.000101	0.000399	CcSEcCtD
Lisdexamfetamine—Insomnia—Hydrocortisone—asthma	0.000101	0.000398	CcSEcCtD
Lisdexamfetamine—Hypertension—Dexamethasone—asthma	0.000101	0.000398	CcSEcCtD
Lisdexamfetamine—Hypertension—Betamethasone—asthma	0.000101	0.000398	CcSEcCtD
Lisdexamfetamine—Anxiety—Betamethasone—asthma	9.93e-05	0.000391	CcSEcCtD
Lisdexamfetamine—Anxiety—Dexamethasone—asthma	9.93e-05	0.000391	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Hydrocortisone—asthma	9.84e-05	0.000387	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Hydrocortisone—asthma	9.72e-05	0.000382	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Hydrocortisone—asthma	9.65e-05	0.00038	CcSEcCtD
Lisdexamfetamine—Fatigue—Hydrocortisone—asthma	9.64e-05	0.000379	CcSEcCtD
Lisdexamfetamine—Vision blurred—Prednisone—asthma	9.6e-05	0.000378	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Betamethasone—asthma	9.55e-05	0.000376	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Dexamethasone—asthma	9.55e-05	0.000376	CcSEcCtD
Lisdexamfetamine—Insomnia—Triamcinolone—asthma	9.52e-05	0.000375	CcSEcCtD
Lisdexamfetamine—Insomnia—Methylprednisolone—asthma	9.5e-05	0.000374	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Triamcinolone—asthma	9.38e-05	0.000369	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Dexamethasone—asthma	9.37e-05	0.000369	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Betamethasone—asthma	9.37e-05	0.000369	CcSEcCtD
Lisdexamfetamine—Agitation—Prednisone—asthma	9.36e-05	0.000368	CcSEcCtD
Lisdexamfetamine—Tachycardia—Dexamethasone—asthma	9.32e-05	0.000367	CcSEcCtD
Lisdexamfetamine—Tachycardia—Betamethasone—asthma	9.32e-05	0.000367	CcSEcCtD
Lisdexamfetamine—Angioedema—Prednisone—asthma	9.31e-05	0.000366	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Triamcinolone—asthma	9.26e-05	0.000365	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Methylprednisolone—asthma	9.24e-05	0.000364	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Dexamethasone—asthma	9.23e-05	0.000363	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Betamethasone—asthma	9.23e-05	0.000363	CcSEcCtD
Lisdexamfetamine—Anorexia—Dexamethasone—asthma	9.1e-05	0.000358	CcSEcCtD
Lisdexamfetamine—Anorexia—Betamethasone—asthma	9.1e-05	0.000358	CcSEcCtD
Lisdexamfetamine—Urticaria—Prednisolone—asthma	9.09e-05	0.000358	CcSEcCtD
Lisdexamfetamine—Fatigue—Triamcinolone—asthma	9.07e-05	0.000357	CcSEcCtD
Lisdexamfetamine—Fatigue—Methylprednisolone—asthma	9.05e-05	0.000356	CcSEcCtD
Lisdexamfetamine—Urticaria—Hydrocortisone—asthma	8.88e-05	0.000349	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Hydrocortisone—asthma	8.84e-05	0.000348	CcSEcCtD
Lisdexamfetamine—Convulsion—Prednisone—asthma	8.83e-05	0.000347	CcSEcCtD
Lisdexamfetamine—Hypertension—Prednisone—asthma	8.8e-05	0.000346	CcSEcCtD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—asthma	8.71e-05	0.00184	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—UTS2—asthma	8.65e-05	0.00182	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCL11—asthma	8.65e-05	0.00182	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—C5AR1—asthma	8.65e-05	0.00182	CbGpPWpGaD
Lisdexamfetamine—Anxiety—Prednisone—asthma	8.65e-05	0.00034	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—BDKRB2—asthma	8.65e-05	0.00182	CbGpPWpGaD
Lisdexamfetamine—Insomnia—Dexamethasone—asthma	8.64e-05	0.00034	CcSEcCtD
Lisdexamfetamine—Insomnia—Betamethasone—asthma	8.64e-05	0.00034	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	8.62e-05	0.000339	CcSEcCtD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—EDN1—asthma	8.57e-05	0.00181	CbGpPWpGaD
Lisdexamfetamine—Hypersensitivity—Prednisolone—asthma	8.43e-05	0.000332	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Betamethasone—asthma	8.41e-05	0.000331	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Dexamethasone—asthma	8.41e-05	0.000331	CcSEcCtD
Lisdexamfetamine—Urticaria—Triamcinolone—asthma	8.36e-05	0.000329	CcSEcCtD
Lisdexamfetamine—Urticaria—Methylprednisolone—asthma	8.34e-05	0.000328	CcSEcCtD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDNRB—asthma	8.34e-05	0.00176	CbGpPWpGaD
Lisdexamfetamine—Body temperature increased—Triamcinolone—asthma	8.32e-05	0.000327	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Prednisone—asthma	8.32e-05	0.000327	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Dexamethasone—asthma	8.3e-05	0.000327	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Betamethasone—asthma	8.3e-05	0.000327	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCR4—asthma	8.3e-05	0.00175	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—asthma	8.26e-05	0.00174	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—asthma	8.26e-05	0.00174	CbGpPWpGaD
Lisdexamfetamine—Gastrointestinal disorder—Betamethasone—asthma	8.24e-05	0.000324	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Dexamethasone—asthma	8.24e-05	0.000324	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Hydrocortisone—asthma	8.24e-05	0.000324	CcSEcCtD
Lisdexamfetamine—Fatigue—Dexamethasone—asthma	8.23e-05	0.000324	CcSEcCtD
Lisdexamfetamine—Fatigue—Betamethasone—asthma	8.23e-05	0.000324	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—C3AR1—asthma	8.16e-05	0.00172	CbGpPWpGaD
Lisdexamfetamine—Nervous system disorder—Prednisone—asthma	8.16e-05	0.000321	CcSEcCtD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ADCY2—asthma	8.14e-05	0.00172	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—asthma	8.12e-05	0.00171	CbGpPWpGaD
Lisdexamfetamine—Tachycardia—Prednisone—asthma	8.12e-05	0.000319	CcSEcCtD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—asthma	8.1e-05	0.00171	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—ALB—asthma	8.08e-05	0.0017	CbGpPWpGaD
Lisdexamfetamine—Skin disorder—Prednisone—asthma	8.08e-05	0.000318	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Prednisone—asthma	8.04e-05	0.000316	CcSEcCtD
Lisdexamfetamine—Asthenia—Hydrocortisone—asthma	8.02e-05	0.000316	CcSEcCtD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—EGFR—asthma	7.99e-05	0.00168	CbGpPWpGaD
Lisdexamfetamine—Anorexia—Prednisone—asthma	7.93e-05	0.000312	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CYSLTR2—asthma	7.86e-05	0.00166	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—AGTR1—asthma	7.82e-05	0.00165	CbGpPWpGaD
Lisdexamfetamine—Hypersensitivity—Triamcinolone—asthma	7.75e-05	0.000305	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Methylprednisolone—asthma	7.74e-05	0.000304	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—C5—asthma	7.71e-05	0.00163	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—TACR1—asthma	7.71e-05	0.00163	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—asthma	7.67e-05	0.00162	CbGpPWpGaD
Lisdexamfetamine—Diarrhoea—Hydrocortisone—asthma	7.65e-05	0.000301	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—LTB4R—asthma	7.59e-05	0.0016	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PTGDR—asthma	7.59e-05	0.0016	CbGpPWpGaD
Lisdexamfetamine—Urticaria—Betamethasone—asthma	7.59e-05	0.000299	CcSEcCtD
Lisdexamfetamine—Urticaria—Dexamethasone—asthma	7.59e-05	0.000299	CcSEcCtD
Lisdexamfetamine—Dizziness—Prednisolone—asthma	7.57e-05	0.000298	CcSEcCtD
Lisdexamfetamine—Asthenia—Triamcinolone—asthma	7.55e-05	0.000297	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Betamethasone—asthma	7.55e-05	0.000297	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Dexamethasone—asthma	7.55e-05	0.000297	CcSEcCtD
Lisdexamfetamine—Asthenia—Methylprednisolone—asthma	7.53e-05	0.000296	CcSEcCtD
Lisdexamfetamine—Insomnia—Prednisone—asthma	7.52e-05	0.000296	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—asthma	7.42e-05	0.00156	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—C3AR1—asthma	7.41e-05	0.00156	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—BDKRB2—asthma	7.41e-05	0.00156	CbGpPWpGaD
Lisdexamfetamine—Dizziness—Hydrocortisone—asthma	7.39e-05	0.000291	CcSEcCtD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—CARM1—asthma	7.38e-05	0.00156	CbGpPWpGaD
Lisdexamfetamine—Dyspepsia—Prednisone—asthma	7.32e-05	0.000288	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Prednisone—asthma	7.23e-05	0.000284	CcSEcCtD
Lisdexamfetamine—Rash—Prednisolone—asthma	7.22e-05	0.000284	CcSEcCtD
Lisdexamfetamine—Dermatitis—Prednisolone—asthma	7.21e-05	0.000284	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Methylprednisolone—asthma	7.19e-05	0.000283	CcSEcCtD
Lisdexamfetamine—Fatigue—Prednisone—asthma	7.17e-05	0.000282	CcSEcCtD
Lisdexamfetamine—Headache—Prednisolone—asthma	7.17e-05	0.000282	CcSEcCtD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CYSLTR2—asthma	7.14e-05	0.0015	CbGpPWpGaD
Lisdexamfetamine—Constipation—Prednisone—asthma	7.11e-05	0.00028	CcSEcCtD
Lisdexamfetamine—Vomiting—Hydrocortisone—asthma	7.11e-05	0.00028	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCR3—asthma	7.06e-05	0.00149	CbGpPWpGaD
Lisdexamfetamine—Rash—Hydrocortisone—asthma	7.05e-05	0.000277	CcSEcCtD
Lisdexamfetamine—Dermatitis—Hydrocortisone—asthma	7.04e-05	0.000277	CcSEcCtD
Lisdexamfetamine—Headache—Hydrocortisone—asthma	7e-05	0.000276	CcSEcCtD
Lisdexamfetamine—Dizziness—Triamcinolone—asthma	6.96e-05	0.000274	CcSEcCtD
Lisdexamfetamine—Dizziness—Methylprednisolone—asthma	6.94e-05	0.000273	CcSEcCtD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PTGDR—asthma	6.89e-05	0.00145	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCL22—asthma	6.89e-05	0.00145	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—LTB4R—asthma	6.89e-05	0.00145	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—NPY—asthma	6.88e-05	0.00145	CbGpPWpGaD
Lisdexamfetamine—Asthenia—Dexamethasone—asthma	6.85e-05	0.00027	CcSEcCtD
Lisdexamfetamine—Asthenia—Betamethasone—asthma	6.85e-05	0.00027	CcSEcCtD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—HMOX1—asthma	6.84e-05	0.00144	CbGpPWpGaD
Lisdexamfetamine—Nausea—Prednisolone—asthma	6.8e-05	0.000267	CcSEcCtD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—KNG1—asthma	6.74e-05	0.00142	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—asthma	6.7e-05	0.00141	CbGpPWpGaD
Lisdexamfetamine—Vomiting—Triamcinolone—asthma	6.69e-05	0.000263	CcSEcCtD
Lisdexamfetamine—Vomiting—Methylprednisolone—asthma	6.68e-05	0.000263	CcSEcCtD
Lisdexamfetamine—Nausea—Hydrocortisone—asthma	6.64e-05	0.000261	CcSEcCtD
Lisdexamfetamine—Rash—Triamcinolone—asthma	6.64e-05	0.000261	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—AGTR2—asthma	6.63e-05	0.0014	CbGpPWpGaD
Lisdexamfetamine—Dermatitis—Triamcinolone—asthma	6.63e-05	0.000261	CcSEcCtD
Lisdexamfetamine—Rash—Methylprednisolone—asthma	6.62e-05	0.000261	CcSEcCtD
Lisdexamfetamine—Dermatitis—Methylprednisolone—asthma	6.62e-05	0.00026	CcSEcCtD
Lisdexamfetamine—Urticaria—Prednisone—asthma	6.61e-05	0.00026	CcSEcCtD
Lisdexamfetamine—Headache—Triamcinolone—asthma	6.59e-05	0.000259	CcSEcCtD
Lisdexamfetamine—Headache—Methylprednisolone—asthma	6.58e-05	0.000259	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Prednisone—asthma	6.57e-05	0.000259	CcSEcCtD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—asthma	6.55e-05	0.00138	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—CARM1—asthma	6.54e-05	0.00138	CbGpPWpGaD
Lisdexamfetamine—Diarrhoea—Dexamethasone—asthma	6.53e-05	0.000257	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Betamethasone—asthma	6.53e-05	0.000257	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PTGDR2—asthma	6.45e-05	0.00136	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HRH4—asthma	6.45e-05	0.00136	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PMCH—asthma	6.45e-05	0.00136	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—NPSR1—asthma	6.45e-05	0.00136	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—asthma	6.35e-05	0.00134	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—EDNRB—asthma	6.35e-05	0.00134	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CSF2RB—asthma	6.32e-05	0.00133	CbGpPWpGaD
Lisdexamfetamine—Dizziness—Betamethasone—asthma	6.32e-05	0.000248	CcSEcCtD
Lisdexamfetamine—Dizziness—Dexamethasone—asthma	6.32e-05	0.000248	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—NPS—asthma	6.29e-05	0.00133	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—TAC1—asthma	6.29e-05	0.00133	CbGpPWpGaD
Lisdexamfetamine—Nausea—Triamcinolone—asthma	6.25e-05	0.000246	CcSEcCtD
Lisdexamfetamine—Nausea—Methylprednisolone—asthma	6.24e-05	0.000245	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCR8—asthma	6.19e-05	0.0013	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—TACR2—asthma	6.19e-05	0.0013	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CXCR3—asthma	6.17e-05	0.0013	CbGpPWpGaD
Lisdexamfetamine—Hypersensitivity—Prednisone—asthma	6.13e-05	0.000241	CcSEcCtD
Lisdexamfetamine—Vomiting—Dexamethasone—asthma	6.07e-05	0.000239	CcSEcCtD
Lisdexamfetamine—Vomiting—Betamethasone—asthma	6.07e-05	0.000239	CcSEcCtD
Lisdexamfetamine—Rash—Dexamethasone—asthma	6.02e-05	0.000237	CcSEcCtD
Lisdexamfetamine—Rash—Betamethasone—asthma	6.02e-05	0.000237	CcSEcCtD
Lisdexamfetamine—Dermatitis—Dexamethasone—asthma	6.02e-05	0.000237	CcSEcCtD
Lisdexamfetamine—Dermatitis—Betamethasone—asthma	6.02e-05	0.000237	CcSEcCtD
Lisdexamfetamine—Headache—Dexamethasone—asthma	5.98e-05	0.000235	CcSEcCtD
Lisdexamfetamine—Headache—Betamethasone—asthma	5.98e-05	0.000235	CcSEcCtD
Lisdexamfetamine—Asthenia—Prednisone—asthma	5.97e-05	0.000235	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—asthma	5.93e-05	0.00125	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—NPSR1—asthma	5.86e-05	0.00124	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PTGDR2—asthma	5.86e-05	0.00124	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HRH4—asthma	5.86e-05	0.00124	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PMCH—asthma	5.86e-05	0.00124	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CSF2RB—asthma	5.74e-05	0.00121	CbGpPWpGaD
Lisdexamfetamine—Diarrhoea—Prednisone—asthma	5.69e-05	0.000224	CcSEcCtD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	5.68e-05	0.0012	CbGpPWpGaD
Lisdexamfetamine—Nausea—Betamethasone—asthma	5.67e-05	0.000223	CcSEcCtD
Lisdexamfetamine—Nausea—Dexamethasone—asthma	5.67e-05	0.000223	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—BDKRB2—asthma	5.64e-05	0.00119	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	5.63e-05	0.00119	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCR8—asthma	5.62e-05	0.00118	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—TACR2—asthma	5.62e-05	0.00118	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCL17—asthma	5.51e-05	0.00116	CbGpPWpGaD
Lisdexamfetamine—Dizziness—Prednisone—asthma	5.5e-05	0.000216	CcSEcCtD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ADCY2—asthma	5.48e-05	0.00115	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—TGFB1—asthma	5.46e-05	0.00115	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—asthma	5.44e-05	0.00115	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PDE4A—asthma	5.41e-05	0.00114	CbGpPWpGaD
Lisdexamfetamine—Vomiting—Prednisone—asthma	5.29e-05	0.000208	CcSEcCtD
Lisdexamfetamine—Rash—Prednisone—asthma	5.24e-05	0.000206	CcSEcCtD
Lisdexamfetamine—Dermatitis—Prednisone—asthma	5.24e-05	0.000206	CcSEcCtD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—asthma	5.23e-05	0.0011	CbGpPWpGaD
Lisdexamfetamine—Headache—Prednisone—asthma	5.21e-05	0.000205	CcSEcCtD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—KNG1—asthma	5.13e-05	0.00108	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—AGTR1—asthma	5.1e-05	0.00108	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	5.08e-05	0.00107	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CYSLTR1—asthma	5.06e-05	0.00107	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CXCL10—asthma	4.98e-05	0.00105	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—asthma	4.96e-05	0.00105	CbGpPWpGaD
Lisdexamfetamine—Nausea—Prednisone—asthma	4.94e-05	0.000194	CcSEcCtD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PDE4A—asthma	4.91e-05	0.00104	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—VIP—asthma	4.89e-05	0.00103	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—UTS2—asthma	4.89e-05	0.00103	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—C5AR1—asthma	4.89e-05	0.00103	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ADCY2—asthma	4.85e-05	0.00102	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—ADRB2—asthma	4.84e-05	0.00102	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—TGFB1—asthma	4.83e-05	0.00102	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—asthma	4.82e-05	0.00102	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCR4—asthma	4.69e-05	0.000989	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—HMOX1—asthma	4.6e-05	0.00097	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CYSLTR1—asthma	4.6e-05	0.00097	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—IL2RB—asthma	4.51e-05	0.000952	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PDE4D—asthma	4.47e-05	0.000943	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—C5AR1—asthma	4.44e-05	0.000937	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—UTS2—asthma	4.44e-05	0.000937	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—VIP—asthma	4.44e-05	0.000937	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCL11—asthma	4.44e-05	0.000937	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FCER2—asthma	4.38e-05	0.000923	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—C3AR1—asthma	4.38e-05	0.000923	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PDE4B—asthma	4.36e-05	0.000919	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—C5—asthma	4.36e-05	0.000919	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—TACR1—asthma	4.36e-05	0.000919	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—EDN1—asthma	4.32e-05	0.000912	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCL5—asthma	4.29e-05	0.000905	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCR4—asthma	4.26e-05	0.000898	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CYSLTR2—asthma	4.22e-05	0.000889	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ALB—asthma	4.11e-05	0.000866	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL2RB—asthma	4.1e-05	0.000864	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—HMOX1—asthma	4.08e-05	0.00086	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PTGDR—asthma	4.07e-05	0.000859	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL22—asthma	4.07e-05	0.000859	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LTB4R—asthma	4.07e-05	0.000859	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PDE4D—asthma	4.06e-05	0.000857	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCR3—asthma	3.99e-05	0.000841	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	3.97e-05	0.000837	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PDE4B—asthma	3.96e-05	0.000835	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—TACR1—asthma	3.96e-05	0.000835	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—C5—asthma	3.96e-05	0.000835	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—NPY—asthma	3.89e-05	0.000819	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	3.88e-05	0.000819	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCR5—asthma	3.87e-05	0.000815	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—C3—asthma	3.78e-05	0.000797	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AGTR2—asthma	3.75e-05	0.00079	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCR3—asthma	3.62e-05	0.000763	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—EDNRB—asthma	3.59e-05	0.000757	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—NPS—asthma	3.55e-05	0.000749	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—TAC1—asthma	3.55e-05	0.000749	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—NPY—asthma	3.53e-05	0.000744	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CXCR3—asthma	3.49e-05	0.000735	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HRH4—asthma	3.46e-05	0.00073	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PTGDR2—asthma	3.46e-05	0.00073	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PMCH—asthma	3.46e-05	0.00073	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NPSR1—asthma	3.46e-05	0.00073	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AGTR2—asthma	3.4e-05	0.000718	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CSF2RB—asthma	3.39e-05	0.000714	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCR8—asthma	3.32e-05	0.0007	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TACR2—asthma	3.32e-05	0.0007	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—IL5—asthma	3.3e-05	0.000697	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—EDNRB—asthma	3.26e-05	0.000687	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL17—asthma	3.26e-05	0.000686	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—NPS—asthma	3.23e-05	0.00068	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—TAC1—asthma	3.23e-05	0.00068	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—BDKRB2—asthma	3.19e-05	0.000672	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCR3—asthma	3.16e-05	0.000667	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADCY2—asthma	3.08e-05	0.00065	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—IL3—asthma	3.07e-05	0.000648	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	3.07e-05	0.000647	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	3.03e-05	0.000639	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—POMC—asthma	3.02e-05	0.000637	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL5—asthma	3e-05	0.000633	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCL2—asthma	2.96e-05	0.000623	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—KIF3A—asthma	2.9e-05	0.000612	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDE4A—asthma	2.9e-05	0.000612	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—KNG1—asthma	2.9e-05	0.000611	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—BDKRB2—asthma	2.89e-05	0.00061	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AGTR1—asthma	2.88e-05	0.000608	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CXCL10—asthma	2.82e-05	0.000594	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADCY2—asthma	2.8e-05	0.000591	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL3—asthma	2.79e-05	0.000589	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ALB—asthma	2.76e-05	0.000583	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADRB2—asthma	2.73e-05	0.000577	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CYSLTR1—asthma	2.72e-05	0.000573	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—KNG1—asthma	2.63e-05	0.000555	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—VIP—asthma	2.62e-05	0.000553	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—C5AR1—asthma	2.62e-05	0.000553	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—UTS2—asthma	2.62e-05	0.000553	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CMA1—asthma	2.62e-05	0.000553	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL11—asthma	2.62e-05	0.000553	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AGTR1—asthma	2.62e-05	0.000552	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ITPR1—asthma	2.59e-05	0.000545	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCL10—asthma	2.56e-05	0.000539	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCR4—asthma	2.52e-05	0.00053	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADRB2—asthma	2.48e-05	0.000524	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—STAT6—asthma	2.47e-05	0.00052	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ALB—asthma	2.45e-05	0.000516	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—EDN1—asthma	2.44e-05	0.000515	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCL5—asthma	2.42e-05	0.000511	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL2RB—asthma	2.42e-05	0.000511	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDE4D—asthma	2.4e-05	0.000506	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CSF2—asthma	2.39e-05	0.000504	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ITPR1—asthma	2.35e-05	0.000495	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—C5—asthma	2.34e-05	0.000493	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDE4B—asthma	2.34e-05	0.000493	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TACR1—asthma	2.34e-05	0.000493	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CXCL8—asthma	2.34e-05	0.000493	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	2.33e-05	0.000491	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—EDN1—asthma	2.22e-05	0.000468	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCL5—asthma	2.2e-05	0.000464	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PLA2G4A—asthma	2.19e-05	0.000463	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCR5—asthma	2.18e-05	0.000461	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CSF2—asthma	2.17e-05	0.000457	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—IL2RA—asthma	2.15e-05	0.000454	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCR3—asthma	2.14e-05	0.000451	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—C3—asthma	2.13e-05	0.00045	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NPY—asthma	2.08e-05	0.000439	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PPP2CA—asthma	2.02e-05	0.000426	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AGTR2—asthma	2.01e-05	0.000424	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCR5—asthma	1.98e-05	0.000418	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL2RA—asthma	1.96e-05	0.000412	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—C3—asthma	1.94e-05	0.000409	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EDNRB—asthma	1.93e-05	0.000406	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TAC1—asthma	1.91e-05	0.000402	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NPS—asthma	1.91e-05	0.000402	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCR3—asthma	1.87e-05	0.000394	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CYBA—asthma	1.81e-05	0.000382	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PARP1—asthma	1.77e-05	0.000374	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL5—asthma	1.77e-05	0.000374	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—BDKRB2—asthma	1.71e-05	0.000361	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—POMC—asthma	1.71e-05	0.00036	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADCY2—asthma	1.65e-05	0.000349	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL3—asthma	1.65e-05	0.000348	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—KNG1—asthma	1.56e-05	0.000328	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—POMC—asthma	1.55e-05	0.000327	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AGTR1—asthma	1.55e-05	0.000326	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCL2—asthma	1.52e-05	0.00032	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL6R—asthma	1.51e-05	0.000319	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCL10—asthma	1.51e-05	0.000319	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—RHOA—asthma	1.5e-05	0.000317	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NTRK1—asthma	1.48e-05	0.000313	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADRB2—asthma	1.47e-05	0.000309	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ITPR1—asthma	1.39e-05	0.000293	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—RHOA—asthma	1.37e-05	0.000288	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CD86—asthma	1.32e-05	0.000279	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CXCL8—asthma	1.32e-05	0.000278	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EDN1—asthma	1.31e-05	0.000276	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL5—asthma	1.3e-05	0.000274	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PLA2G4A—asthma	1.3e-05	0.000273	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CSF2—asthma	1.28e-05	0.00027	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—IL2—asthma	1.26e-05	0.000266	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SMAD3—asthma	1.25e-05	0.000263	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCL8—asthma	1.2e-05	0.000253	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PPP2CA—asthma	1.19e-05	0.000252	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCR5—asthma	1.17e-05	0.000247	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL2RA—asthma	1.16e-05	0.000244	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL2—asthma	1.15e-05	0.000242	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—C3—asthma	1.15e-05	0.000241	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDGFB—asthma	1.11e-05	0.000235	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LEP—asthma	1.07e-05	0.000225	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FN1—asthma	1.01e-05	0.000212	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—POMC—asthma	9.16e-06	0.000193	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL2—asthma	8.96e-06	0.000189	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL6R—asthma	8.93e-06	0.000188	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—EGFR—asthma	8.77e-06	0.000185	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SERPINE1—asthma	8.37e-06	0.000176	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RHOA—asthma	8.07e-06	0.00017	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NOS3—asthma	7.99e-06	0.000168	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCL8—asthma	7.09e-06	0.000149	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL2—asthma	6.77e-06	0.000143	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL6—asthma	6.74e-06	0.000142	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MMP9—asthma	6.41e-06	0.000135	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PTEN—asthma	6.37e-06	0.000134	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—VEGFA—asthma	5.75e-06	0.000121	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—STAT3—asthma	5.7e-06	0.00012	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TGFB1—asthma	5.28e-06	0.000111	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EGFR—asthma	5.18e-06	0.000109	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL6—asthma	3.98e-06	8.39e-05	CbGpPWpGaD
